SCHEDULE: Dimensional Fund Advisors Updates Avanos Medical Stake

Dimensional Fund Advisors LP has filed an amendment to its Schedule 13G, disclosing a 4.6% beneficial ownership stake in Avanos Medical Inc. as of December 31, 2025.

Summary

• Dimensional Fund Advisors LP reported beneficial ownership of 2,157,531 shares of Avanos Medical Inc. common stock.
• This represents 4.6% of the class of securities.
• The firm holds sole voting power over 2,087,813 shares and sole dispositive power over 2,157,531 shares.
• Dimensional Fund Advisors LP acts as an investment adviser to various funds that own these securities and disclaims beneficial ownership, holding power for Section 13(d) purposes only.
• The securities were acquired and are held in the ordinary course of business, without the purpose or effect of changing or influencing the control of Avanos Medical Inc.

Sentiment

Score: 5

Explanation: The filing is a routine disclosure of passive beneficial ownership by an institutional investor. It contains no positive or negative news about the issuer, Avanos Medical Inc., nor does it indicate any intent to influence control. The sentiment is neutral as it's purely informational regarding a stake below 5%.

Positives

• The filing indicates continued investment by a significant institutional investor, Dimensional Fund Advisors LP, in Avanos Medical Inc.
• The stake is held in the ordinary course of business, suggesting a passive investment strategy without intent to influence control.

Negatives

• No specific negative information is disclosed in this passive ownership filing.

Risks

• No specific risks related to Avanos Medical Inc. are mentioned in this filing, as it pertains to an investor's stake.

Future Outlook

NA

Industry Context

This filing is a routine disclosure by an institutional investment adviser, reflecting its passive stake in a medical technology company. It does not provide specific insights into broader industry trends or competitive landscape beyond the fact that a major fund manager continues to hold shares in the sector.

Key Dates

Keywords

Avanos Medical Inc, Dimensional Fund Advisors, Schedule 13G, Beneficial Ownership, Common Stock, Institutional Investor, AVNS